Microbiome Contract Research Services

Over a decade of proven experience in oral, skin, and gut microbiome analysis

We provide full-service microbiome analysis tailored to your research or product development goals. Our workflow includes:

Option A: Send extracted DNA → we perform NGS + analysis
- 16S rRNA-based metagenomics
- Coverage across V1–V9 regions for species-level resolution
Option B: Send fastq files → we deliver advanced statistical and functional analyses
- Including metabolic predictions and customizable pipelines

From clinical studies to biomarker discovery, our CRO service supports your research from raw sample to functional interpretation.

Our microbiome CRO service follows a collaborative and flexible workflow to meet your research goals across skin, oral, and gut microbiomes.

Workflow:

Pre-analysis consultation
We discuss your research objectives and data types to define the optimal analysis strategy.
Proposal & NDA
Based on the discussion, we prepare a detailed analysis proposal. NDA can be arranged upon request.
Analysis execution
Upon confirmation, we perform the analysis as proposed using our in-house software and databases.
Reporting
Results are delivered in a comprehensive report with statistical and biological interpretation.

Customizable Analysis Options:

Identification of significantly altered microbial taxa
Biomarker discovery and classification
Functional prediction and metabolic pathway analysis
Literature-backed insight using our proprietary databases and AI-powered engines

We aim to provide the most up-to-date interpretation possible, leveraging both computational tools and domain expertise.

Microbiome Seed Discovery Services

Find your next lead compound — from the microbiome

Our platform leverages in-house databases and proprietary analytics to discover functional bioactives and seed compounds from:

Gut microbiota
Skin microbiome
Oral microbiome

Supporting both ingredient development and novel therapeutics, this service helps you translate microbial insights into material innovation.

Case Study

In one project, our platform was used to support the development of a toothpaste targeting oral microbiota, specifically Porphyromonas gingivalis (P. gingivalis), a key bacterium in the red complex linked to periodontal disease.

Workflow Overview:

Target identification:
We selected P. gingivalis as the primary target for functional suppression.
Natural compound screening using AI:
Our literature-based AI engine was used to identify potential natural compounds reported to inhibit P. gingivalis.
Filtering by MIC (Minimum Inhibitory Concentration):
We referenced assay data to select compounds with low MIC values against P. gingivalis, ensuring effectiveness at low concentrations.
Ingredient feasibility check:
From the MIC-screened list, we narrowed down to compounds that are available as safe, usable raw materials for formulation.

Validation: A small-scale microbiome trial showed a reduction in red complex bacteria, supporting the functional effect of the developed product.

This example focused on identifying readily available natural materials. However, our platform also enables:

Lead compound discovery
Small molecule seed molecule identification
Mechanism-guided compound ranking

All powered by our proprietary AI engine, compound–microbiome interaction database, and customizable discovery pipeline.

Whether you’re developing cosmetics, food products, or pharmaceuticals, we support a wide range of microbiome-driven material innovation.